ESC Premium Access

A deep dive into mitral regurgitation

Event: ESC Congress 2021 - The Digital Experience
Topic: Mitral Valve Regurgitation
Session type: Abstract Sessions
Date: 27 August 2021
Time: 20:15 - 21:00

Congress Session

5 presentations in this session

Circulating transforming growth factor-beta1 and progression of the mitral valve prolapse: fifteen-year follow-up

Speaker: Professor E. Malev (Saint Petersburg, RU)

Trends in incidence and mortality from non-rheumatic degenerative mitral valve disease across europe, over the past three decades.

Speaker: Doctor B. Al-khayatt (London, GB)

The MIDA Quantitative mortality risk score: prognostic model in floppy mitral valves

Speaker: Doctor B. Essayagh (Rochester, US)

Myocardial efficiency in severe asymptomatic primary mitral regurgitation: relation to quantitative measures of regurgitation

Speaker: Professor J. Sorensen (Uppsala, SE)

Clinical and haemodynamic effects of percutaneous edge-to-edge mitral valve repair in atrial versus ventricular functional mitral regurgitation

Speaker: Professor M. Claeys (Antwerp, BE)

5 speakers from this session

Professor Eduard Malev

Almazov National Medical Research Centre, Saint Petersburg (Russian Federation)
0 follower

Doctor Becker Al-khayatt

East Surrey Hospital, London (United Kingdom of Great Britain & Northern Ireland)
0 follower

Doctor Benjamin Essayagh

Mayo Clinic, Rochester (United States of America)
0 follower

Professor Jens Sorensen

Uppsala University, Uppsala (Sweden)
0 follower

Professor Marc Claeys

University of Antwerp, Antwerp (Belgium)
6 presentations
1 follower

This platform is supported by

logo Novo Nordisk